We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$10.9B
AUM Growth
+$1.67B
Cap. Flow
+$806M
Cap. Flow %
7.42%
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150

Sector Composition

Rank Sector Weight
1 Healthcare 38.5%
2 Technology 22.75%
3 Industrials 9.82%
4 Energy 8.34%
5 Consumer Discretionary 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHS
676
DELISTED
Chicos FAS, Inc.
CHS
-689,026
Closed -$5.22M
INBX
677
DELISTED
Inhibrx, Inc. Common Stock
INBX
-2,318,576
Closed -$88.1M

Similar funds

Woodline Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.

  • Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
  • Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
  • Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
  • Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
  • Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
  • Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
  • Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.

Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.